Board summary
Key figures
47,814
Registered population
58.0% aged 18–64
23.1%
Aged 65+
ICB 20.0% · England 17.9%
7.8%
Ethnic minority (non-White)
5.9% Asian · England 9.6%
26.3%
In IMD quintile 1
ICB 30.6% · England 21.0%
~11,989
Core20 residents (est.)
Resident basis; registered basis ~12,540 · see page 3
8,135
Hypertension register
+4.99% in 3 yrs · England +5.60%
549
SMI register
48.5% of Pendle's
1,376
COPD register
Reviews -4.10% in 3 yrs
Forecast to 2030
9,062
Hypertension patients, 2030
+927 on today
60.4%
QRISK ≥20% on statins, 2030
+0.65pp over 3 yrs
5.6%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma annual review coverage trails benchmarks.
Asthma review coverage is 55.6% (England 65.7%; -2.0% over 2023 to 2025 vs +4.4%), leaving about 1,600 patients unreviewed; a recall audit could test.
SMI physical health checks lag England.
SMI blood pressure recording is 76.0% (England 83.4%; The Richmond Hill Practice 70.0%) and BMI 72.6% (England 82.1%), which may reflect outreach gaps testable.
Hypertension treatment to target improved faster than England.
Hypertension treatment to threshold rose +9.4% over 2023 to 2025 (England +3.6%) to 69.5% (Pendle 68.4%; England 70.3%), and 80+ BP control rose +8.3%.
Population, age and ethnicity
Pendle East PCN has an older demographic, with 23.1% of patients aged 65+
Pendle East PCN serves 47,814 registered patients with an older age profile: 23.1% (11,047 patients) are aged 65+, above Pendle (17.0%), the ICB (20.0%), and England (17.9%). Census usual resident data, which reflects local catchment areas rather than practice-verified registered ethnicity, records 92.2% White residents compared with 70.6% in Pendle, 87.8% across the ICB, and 81.1% nationally. Asian or Asian British residents make up 5.9%, below Pendle (26.7%), the ICB (9.4%), and England (9.6%).
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Pendle local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Pendle LA) | 1,461 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 82.7% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 54.7% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Pendle LA) | 712 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Pendle LA) | 13.6 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation is 26.3% overall and spans 51.5 pp across member practices
Pendle East PCN's Core20 share is 26.3%, above England (21.0%) but below Pendle (46.6%) and NHS Lancashire and South Cumbria Integrated Care Board (30.6%), with an average IMD decile of 4.3 (England 5.5). Deprivation is uneven: Barrowford Surgery has a 0.0% Core20 share, The Pendle Medical Partnership has 27.47% (4,107 estimated patients), and The Richmond Hill Practice has a 51.54% Core20 share (6,548 estimated patients), spanning a 51.5 pp range. Estimated resident Core20 population is 11,989. Deprivation is concentrated in specific practices, meaning targeted support could focus on communities with.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
549
SMI register
1.14% recorded prevalence
186
Learning disability register
0.39% recorded prevalence
15
Care homes, 573 beds
In the PCN catchment
9.5%
Provide unpaid care
Pendle, Census 2021
The learning disability register records 186 patients (0.4%), trailing Pendle (0.5%), the ICB (0.6%), and England (0.6%), with a modelled shortfall of 70 to 95 patients. The severe mental illness register includes 549 patients (1.1%), while 15 care homes offer 573 beds across the catchment. Crude register prevalence does not establish unmet need or under-detection, which requires local clinical audit.
Severe mental illness: physical health checks
On the SMI register, 76.0% received a blood pressure check (England 83.4%), dropping to 70.0% at The Richmond Hill Practice and 74.0% at Barnoldswick Med Ctr. BMI recording reached 72.6% (England 82.1%). This may reflect outreach gaps, unverified locally.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
8,135
Hypertension register
+4.99%
Register growth, 3 yrs
Pendle +3.69% · England +5.60%
+3.39pp
BP control, under 80
≤140/90 · +6.18pp aged 80+
+927
More patients by 2030
Forecast 9,062 (18.67%)
Hypertension case-finding and control
Hypertension register prevalence is 16.9% (8,135 patients), above England (15.2%) and Pendle (14.9%). Blood pressure recording reached 88.9% (England 90.0%), and patients treated to target rose +9.4% over 2023 to 2025 (England +3.6%) to 69.5% (England 70.3%). However, blood pressure control among patients aged under 80 is 63.1%, trailing England (67.8%) and NHS Lancashire and South Cumbria Integrated Care Board (67.1%), while control in patients aged 80 and over reached 80.7% (England 81.2%). Lower blood pressure control in patients aged under 80 indicates that proactive recall and therapy optimisation for this cohort could be prioritised.
Lipids and statins
Lipid-lowering therapy coverage for patients with QRISK ≥ 20% is 59.1%, trailing Pendle (66.2%) and England (63.6%), having grown +1.1% over 2023 to 2025 (England +6.2%). Statin coverage in diabetes without cardiovascular disease is 69.0% (England 73.2%). Lower therapy uptake suggests prioritising clinical audits of at-risk registers.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 88,745 | £2.10 | £1.64 | £1.86 | £186,364 |
| Cardiovascular (all), 2025 | 134,479 | £3.91 | £3.38 | £3.33 | £525,813 |
In 2026, the PCN prescribed 88,745 lipid-regulating items at £2.10 per item, compared with £1.86 in England and £1.64 across NHS Lancashire and South Cumbria Integrated Care Board. The PCN spent £21,299 more than at England's unit cost and £40,823 more than the ICB's across these items. These figures reflect unit-cost indicators rather than savings targets or clinical efficiency measures.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−1.99%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+0.30%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 7.8% (3,552 patients; England 6.6%), but review coverage is 55.6% (England 65.7%), having fallen 2.0% over 2023 to 2025 (England +4.4%), leaving about 1,600 unreviewed patients. Paediatric prescribing is 1,862 items per 1,000 aged 5-19 (England 1,488), while second-hand smoke recording is 62.8% (England 78.8%). COPD prevalence is 2.9% (1,376 patients; England 1.9%), but reviews fell 4.1% over 2023 to 2025 (England +2.8%) to 69.3% (England 76.4%). These declines could reflect recall gaps, unverified locally.
Cancer register and children's immunisation
Cancer prevalence is 4.5% (2,181 patients; England 3.8%). In Q1 2025/26, 6-in-1 coverage at 24 months reached 98.4%, but 12-month coverage was 88.9% (England 91.0%), below the 95.0% target by 6.1 pp. Age-five MMR second dose reached 85.1% versus 94.2% for dose 1, with a 20.5 pp difference at The Pendle Medical Partnership (94.9% to 74.4%), which could reflect recall barriers, unverified locally.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In 2022, 52.4% of cancers with a known stage (4,642 of 8,863) in NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 pp below the 75.0% national ambition by 2028 (with 74.6% known-stage coverage, 8,863 of 11,883). These figures reflect wider system staging, not PCN performance. PCN cancer prevalence is 4.5% (2,181 patients), rising +11.1% over 2023 to 2025 (England +9.0%). Cervical screening is 71.0% (England 66.8%), with 68.0% at The Richmond Hill Practice and 68.4% at Barnoldswick Med Ctr, but fell 1.8% over 2023 to 2025 (England -1.0%). Sustaining proactive screening uptake across all practices is essential to support earlier.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026, East Lancashire Hospitals NHS Trust met the 75.0% faster diagnosis standard at 81.5% (Airedale NHS Foundation Trust 87.7%, Bradford Teaching Hospitals NHS Foundation Trust 78.2%, ICB 78.4%, England 79.3%). However, its 62-day treatment rate was 73.2% against the 85.0% standard, trailing Airedale NHS Foundation Trust (88.9%) and NHS Lancashire and South Cumbria Integrated Care Board (73.6%), but above England (71.2%) and Bradford Teaching Hospitals NHS Foundation Trust (68.1%). Diagnostics waiting 6+ weeks were 0.4% for MRI and 0.1% for CT (England 21.4% and 9.9%). Secondary care treatment backlogs risk delaying care after prompt diagnosis.
| Pathways within standard (%) | East Lancashire | Airedale | Bradford | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 81.50 | 87.71 | 78.19 | 78.39 | 79.32 |
| 31-day treatment (96%) | 98.11 | 98.20 | 96.90 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 73.16 | 88.89 | 68.05 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Lancashire | Airedale | Bradford | England |
|---|---|---|---|---|
| MRI | 0.43 | 2.91 | 1.15 | 21.40 |
| CT | 0.15 | 0.00 | 0.00 | 9.92 |
| Echocardiography | 0.00 | 0.70 | 14.41 | 28.48 |
| Colonoscopy | 0.95 | 31.21 | 6.77 | 30.83 |
| Gastroscopy | 1.16 | 22.98 | 22.31 | 29.02 |
| All 15 DM01 tests | 3.25 | 4.33 | 13.74 | 23.14 |
| Community services activity | Lancashire residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 126,445 | 193,720 |
| Referrals | 20,415 | 29,855 |
| Patients with a contact | 47,320 | 65,335 |
Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026 provisional Community Services Dataset reporting, 56.9% of borough residents' community contacts (72,000 of 126,445 contacts) were with adults aged 65 and over. These figures describe wider borough community activity, not PCN performance, as PCN-level activity was not captured.
Practice variation and patient experience
High clinical QOF achievement contrasts with wide vaccination and phone access disparities
Clinical-domain QOF achievement is at least 99.6% across all practices, reaching 100.0% at three practices. Vaccination and immunisation achievement spans 56.0 pp, reaching 20.0% at The Richmond Hill Practice, 24.9% at The Pendle Medical Partnership (England 55.2%), and 76.0% at Barnoldswick Med Ctr. All-domain personalised care adjustments reach 15.9% at The Richmond Hill Practice.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Barrowford Surgery | 105 | 0.0 | 88.7% | 73.2% | 89.3% |
| Harambee Surgery | 104 | 10.2 | 94.0% | 79.2% | 80.4% |
| Barnoldswick Med | 109 | 11.9 | 50.9% | 75.1% | 77.4% |
| Pendle Medical | 104 | 27.5 | 28.1% | 66.1% | 59.2% |
| Richmond Hill | 137 | 51.5 | 25.9% | 56.9% | 58.8% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Sixteen of 25 measures trail England over three years, led by falling reviews
Over 2023 to 2025, 16 of 25 measures trailed England's three-year change. The widest lag was heart failure reviews, which fell 8.1% (England +8.7%), leaving current coverage at 69.6% (England 78.5%). Dementia prevalence fell 10.7% (England +6.0%) and stroke fell 2.7% (England +2.3%). Conversely, hypertension patients treated to target rose +9.4% (England +3.6%) and blood pressure control at age 80+ rose +8.3% (England +2.2%). Trailing registers could reflect diagnostic coding patterns rather than lower morbidity, unverified locally without clinical record audit.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
Dementia register
COPD reviews
Asthma reviews
QRISK statin treatment
Hypertension BP reading
BP control, 80+
Hypertension treated to target
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Pendle | Asset | PCN | Pendle |
|---|---|---|---|---|---|
| Care homes (catchment) | 15 (573 beds) | n/a | Schools (catchment) | 60 | n/a |
| Children's centres | 5 | 7 | Places of worship | 52 | 71 |
| Libraries | 6 | 8 | Primary schools (LA maintained) | 15 | 22 |
| Primary academies | 7 | 9 | Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma annual review recall
Asthma review coverage is 55.6% (Pendle 59.7%; ICB 65.0%; England 65.7%), falling 2.0% over 2023 to 2025 (England +4.4%), leaving 1,577 (about 1,600) of 3,552 patients unreviewed. For discussion, practices could run structured annual review recall using a single template and flexible slots, checking inhaler prescribing alongside reviews. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Learning disability register validation
Learning disability prevalence is 0.4% (186 of 47,814 patients; Pendle 0.5%; ICB 0.6%; England 0.6%), growing +3.3% over 2023 to 2025 (Pendle +10.0%; England +5.4%), a modelled gap of +70 to +95. Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Option 3
SMI physical health check outreach
On the 549-patient SMI register, blood pressure recording is 76.0% (Pendle 76.4%; ICB 79.8%; England 83.4%), reaching 70.0% at The Richmond Hill Practice and 74.0% at Barnoldswick Med Ctr; BMI is 72.6% (England 82.1%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Targeted Core20 outreach and reviews (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Targeted SMI physical health clinics (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension medication titration reviews (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school MMR second-dose recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall improvement (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Structured asthma annual review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Learning disability register validation (p12) | Learning disability register · Learning disability: QOF prevalence · Registered population | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
| Option 3 · SMI physical health check outreach (p12) | Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
